Do you want to read an article? Please log in or register.
Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced/Metastatic NSCLC
Lung, Respiratory and Thoracic Cancer
